Low-Grade Glioma

  • Rolf-Dieter KortmannEmail author
  • Arnold C. Paulino


Local tumour control is the cornerstone in the general management of childhood low-grade glioma. Treatment traditionally consists of surgery and biopsy in areas not amenable to resection. Non-surgical treatment is usually performed upon progression. Although chemotherapy is increasingly used as first non-surgical treatment, radiotherapy remains standard as salvage treatment or as primary treatment in selected cases in which surrounding normal tissue can be optimally preserved. The effects of chemotherapy on improving the clinical, neurological, visual and endocrinological function deserve further investigation. Recent improvements in radiotherapy treatment and delivery techniques allow better coverage of target volume and assure maximal tumour control while sparing as much normal tissue as possible to reduce the risk of toxicity secondary to treatment. Additionally, the implementation of modern imaging technologies including functional imaging permits a better identification of the tumour site and neighbouring normal tissue or organs at risk thereby further reducing the risk for late adverse effects. Intensity-modulated radiotherapy (IMRT), stereotactic high precision technologies and the introduction of proton therapy may further improve treatment outcome. Brachytherapy, or in rare cases radiosurgery, is a treatment option in low-grade glioma; however, clinical data are scarce and require more research. The role of targeted therapies is currently under investigation in clinical trials. New information on molecular genetic patterns in low-grade glioma may also have an impact on the selection and sequencing of radiotherapy.


  1. Alvord EC Jr, Lofton S (1988) Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J Neurosurg 68:85–98CrossRefPubMedGoogle Scholar
  2. Armstrong GT, Conklin HM, Huang S, Srivastava D, Sanford R, Ellison DW, Merchant TE, Hudson MM, Hoehn ME, Robison LL, Gajjar A, Morris EB (2011) Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro-Oncology 13(2):223–234CrossRefPubMedGoogle Scholar
  3. Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH, Pollack IF (2012) Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children’s Oncology Group. J Clin Oncol 30(21):2641–2647CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ (1996) Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer 78:864–873CrossRefPubMedGoogle Scholar
  5. Bhargava D, Sinha P, Chumas P, Al-Tamimi Y, Shivane A, Chakrabarty A, Surash S, Novegno F, Crimmins D, Tyagi AK (2013) Occurrence and distribution of pilomyxoid astrocytoma. Br J Neurosurg 27(4):413–418CrossRefPubMedGoogle Scholar
  6. Bian SX, McAleer MF, Vats TS, Mahajan A, Grosshans DR (2013) Pilocytic astrocytoma with leptomeningeal dissemination. Childs Nerv Syst 29(3):441–450CrossRefPubMedGoogle Scholar
  7. Boëthius J, Ulfarsson E, Rähn T, Lippittz B (2002) Gamma knife radiosurgery for pilocytic astrocytomas. J Neurosurg 97(5 Suppl):677–678PubMedGoogle Scholar
  8. Chalil A, Ramaswamy V (2016) Low grade gliomas in children. J Child Neurol 31(4):517–522CrossRefPubMedGoogle Scholar
  9. Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J (2005) Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 62(3):814–819CrossRefPubMedGoogle Scholar
  10. Creach KM, Rubin JB, Leonard JR, Limbrick DD, Smyth MD, Dacey R, Rich KM, Dowling JL, Grubb RL Jr, Linette GP, King AA, Michalski JM, Park TS, Perry A, Simpson JR, Mansur DB (2012) Oligodendrogliomas in children. J Neuro-Oncol 106(2):377–382CrossRefGoogle Scholar
  11. Dasgupta T, Haas-Kogan DA (2013) The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas. Front Oncol 3:110CrossRefPubMedPubMedCentralGoogle Scholar
  12. Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom SS (2013) Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas. Investig New Drugs 31(5):1136–1141CrossRefGoogle Scholar
  13. Debus J, Kocagoncu KO, Hoss A, Wenz F, Wannenmacher M (1999) Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 44:243–248CrossRefPubMedGoogle Scholar
  14. Dennis ER, Bussiere MR, Niemierko A, Lu MW, Fullerton BC, Loeffler JS, Shih HA (2013) A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy. Technol Cancer Res Treat 12(1):1–9CrossRefPubMedGoogle Scholar
  15. Dodgshun AJ, Maixner WJ, Heath JA, Sullivan MJ, Hansford JR (2016) Single agent carboplatin for pediatric low-grade glioma: a retrospective analysis shows equivalent efficacy to multiagent chemotherapy. Int J Cancer 138(2):481–488CrossRefPubMedGoogle Scholar
  16. Fisher BJ, Bauman GS, Leighton CE, Stitt L, Cairncross JG, Macdonald DR (1998) Low-grade gliomas in children: tumor volume response to radiation. J Neurosurg 88:969–974CrossRefPubMedGoogle Scholar
  17. Fisher PG, Tihan T, Goldthwaite PT, Wharam MD, Carson BS, Weingart JD, Repka MX, Cohen KJ, Burger PC (2008) Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51(2):245–250CrossRefPubMedGoogle Scholar
  18. Flickinger JC, Torres C, Deutsch M (1988) Management of low-grade gliomas of the optic nerve and chiasm. Cancer 61:635–642CrossRefPubMedGoogle Scholar
  19. Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL (2003) Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children’s Cancer Group high-grade glioma study CCG-945. Cancer 98(6):1243–1252CrossRefPubMedGoogle Scholar
  20. Garcia DM, Marks JE, Latifi HR, Kliefoth AB (1990) Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? Int J Radiat Oncol Biol Phys 18:815–818CrossRefPubMedGoogle Scholar
  21. Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro-Oncology 14(10):1265–1284CrossRefPubMedPubMedCentralGoogle Scholar
  22. Grabenbauer GG, Schuchardt U, Buchfelder M, Rodel CM, Gusek G, Marx M, Doerr HG, Fahlbusch R, Huk WJ, Wenzel D, Sauer R (2000) Radiation therapy of optico-hypothalamic gliomas (OHG)—radiographic response, vision and late toxicity. Radiother Oncol 54:239–245CrossRefPubMedGoogle Scholar
  23. Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, Yock TI (2014) Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys 89(5):1060–1068CrossRefPubMedGoogle Scholar
  24. Hadjipanayis CG, Kondziolka D, Flickinger JC, Lunsford LD (2003) The role of stereotactic radiosurgery for low-grade astrocytomas. Neurosurg Focus 14(5):e15CrossRefPubMedGoogle Scholar
  25. Heppner PA, Sheehan JP, Steiner LE (2005) Gamma knife surgery for low-grade gliomas. Neurosurgery 57(6):1132–1139CrossRefPubMedGoogle Scholar
  26. Herrera EJ, Viano JC, Gómez JM, Surur A, Suárez JC (2007) Interstitial stereotactic radiosurgery of pilocytic astrocytomas in paediatric patients. Acta Neurochir 149(9):887–896CrossRefPubMedGoogle Scholar
  27. Horbinski C, Nikiforova MN, Hagenkord JM, Hamilton RL, Pollack IF (2012) Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. Neuro-Oncology 14(6):777–789CrossRefPubMedPubMedCentralGoogle Scholar
  28. von Hornstein S, Kortmann RD, Pietsch T, Emser A, Warmuth-Metz M, Soerensen N, Straeter R, Graf N, Thieme B, Gnekow AK (2011) Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial. Pediatr Blood Cancer 56(7):1046–1054CrossRefGoogle Scholar
  29. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, Grove RI, Slater JD (2002) Conformal proton radiation therapy for pediatric low-grade astrocytoma. Strahlenther Onkol 178:10–17CrossRefPubMedGoogle Scholar
  30. Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R (2010) Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 77(4):974–979CrossRefPubMedGoogle Scholar
  31. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT (1995) Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051–1059CrossRefPubMedGoogle Scholar
  32. Jenkin D, Angyalfi S, Becker L, Berry M, Buncic R, Chan H, Doherty M, Drake J, Greenberg M, Hendrick B (1993) Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215–225CrossRefPubMedGoogle Scholar
  33. Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, Liu L, Bäcklund LM, Ichimura K, Collins VP (2011) Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts. Acta Neuropathol 121(6):753–761CrossRefPubMedGoogle Scholar
  34. Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 17(4):348–352CrossRefPubMedGoogle Scholar
  35. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Pollack IF, Jakacki RI, Lunsford LD (2009) Stereotactic radiosurgery for pilocytic astrocytomas part 2: outcomes in pediatric patients. J Neuro-Oncol 95(2):219–229CrossRefGoogle Scholar
  36. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J (2001) Population-based epidemiologic data on brain tumors in German children. Cancer 92(12):3155–3164Google Scholar
  37. Korinthenberg R, Neuburger D, Trippel M, Ostertag C, Nikkhah G (2011) Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas. Int J Radiat Oncol Biol Phys 79(4):1131–1138CrossRefPubMedGoogle Scholar
  38. Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT’91. Int J Radiat Oncol Biol Phys 46(2):269–279Google Scholar
  39. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M (2003a) Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: treatment-related late toxicity. Strahlenther Onkol 179(9):585–597CrossRefPubMedGoogle Scholar
  40. Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M (2003b) Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: treatment modalities of radiation therapy. Strahlenther Onkol 179(8):509–520CrossRefPubMedGoogle Scholar
  41. Kovalic JJ, Grigsby PW, Shepard MJ, Fineberg BB, Thomas PR (1990) Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18:927–932CrossRefPubMedGoogle Scholar
  42. Listernik R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis I: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143–149CrossRefGoogle Scholar
  43. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentralGoogle Scholar
  44. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ (2005) Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys 61(2):374–379CrossRefPubMedGoogle Scholar
  45. Mazloom A, Hodges JC, Teh BS, Chintagumpala M, Paulino AC (2012) Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys 84(2):350–354CrossRefPubMedGoogle Scholar
  46. Merchant TE, Goloubeva O, Pritchard DL, Gaber MW, Xiong X, Danish RK, Lustig RH (2002) Radiation dose–volume effects on growth hormone secretion. Int J Radiat Oncol Biol Phys 52:1264–1270CrossRefPubMedGoogle Scholar
  47. Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA (2009) Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol 27(22):3598–3604CrossRefPubMedPubMedCentralGoogle Scholar
  48. Mishima K, Nakamura M, Nakamura H, Nakamura O, Funata N, Shitara N (1992) Leptomeningeal dissemination of cerebellar pilocytic astrocytoma. Case Report J Neurosurg 77:788–791PubMedGoogle Scholar
  49. Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA (2006) The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro-Oncology 8(2):166–174CrossRefPubMedPubMedCentralGoogle Scholar
  50. Montgomery AB, Griffin T, Parker RG, Gerdes AJ (1977) Optic nerve glioma: the role of radiation therapy. Cancer 40:2079–2080CrossRefPubMedGoogle Scholar
  51. Mueller K, Gnekow A, Warmuth-Metz M, Pietsch T, Zwiener I, Falkenstein F, Meyer F-M, Micke O, Hoffmann W, Kortmann RD (2012) Effectivity of radiation-therapy in pediatric “high-risk” low-grade astrocytoma—a preliminary experience from the two prospective German multicenter treatment studies HIT LGG 1996 & HIT-LGG 2004. Neuro-Oncology 14(suppl 1):69–81CrossRefGoogle Scholar
  52. Mueller K, Gnekow A, Falkenstein F, Scheiderbauer J, Zwiener I, Pietsch T, Warmuth-Metz M, Voges J, Nikkhah G, Flentje M, Combs SE, Vordermark D, Kocher M, Kortmann RD (2013) Radiotherapy in pediatric pilocytic astrocytomas: a subgroup analysis within the prospective multicenter study HIT-LGG 1996 by the German Society of Pediatric Oncology and Hematology (GPOH). Strahlenther Onkol 189(8):647–655CrossRefGoogle Scholar
  53. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86(5):747–754CrossRefPubMedGoogle Scholar
  54. Park KJ, Kano H, Kondziolka D, Niranjan A, Flickinger Jc, Lunsford LD (2011) Gamma Knife surgery for subependymial giant cell astrocytomas. J Neurosurg 114(3):808–813Google Scholar
  55. Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, Teh BS, Chintagumpala M (2013) Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer 119(14):2654–2659CrossRefPubMedGoogle Scholar
  56. Peraud A, Goetz C, Siefert A, Tonn JC, Kreth FW (2007) Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study. Childs Nerv Syst 23(1):39–46CrossRefPubMedGoogle Scholar
  57. Pollack IF, Hurtt M, Pang D, Albright AL (1994) Dissemination of low grade intracranial astrocytomas in children. Cancer 1994(73):2869–2878CrossRefGoogle Scholar
  58. Pollack IF, Claassen D, al Shboul Q, Janosky JE, Deutsch M (1995) Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. J Neurosurg 82:536–547CrossRefPubMedGoogle Scholar
  59. Raabe E, Kieran MW, Cohen KJ (2013) New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res 19(17):4553–4558CrossRefPubMedPubMedCentralGoogle Scholar
  60. Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J (2011) Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 29(31):4151–4159CrossRefPubMedGoogle Scholar
  61. Saran FH, Baumert BG, Khoo VS, Adams EJ, Garré ML, Warrington AP, Brada M (2002) Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int J Radiat Oncol Biol Phys 53(1):43–51CrossRefPubMedGoogle Scholar
  62. Steen RG, Spence D, Wu S, Xiong X, Kun LE, Merchant TE (2001) Effect of therapeutic ionizing radiation on the human brain. Ann Neurol 50:787–795CrossRefPubMedGoogle Scholar
  63. Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro-Oncology 12(12):1257–1268PubMedPubMedCentralGoogle Scholar
  64. Sung DI (1982) Suprasellar tumors in children: a review of clinical manifestations and managements. Cancer 50:1420–1425CrossRefPubMedGoogle Scholar
  65. Weintraub D, Yen CP, Xu Z, Savage J, Williams B, Sheehan J (2012) Gamma knife surgery of pediatric gliomas. J Neurosurg Pediatr 10(6):471–477CrossRefPubMedGoogle Scholar
  66. Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN (2013) Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol 35(3):197–205CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Radiation TherapyUniversity of LeipzigLeipzigGermany
  2. 2.Department of Radiation OncologyMD Anderson Cancer CenterHoustonUSA

Personalised recommendations